CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 52 filers reported holding CIDARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,009 | -39.9% | 55,200 | -27.9% | 0.00% | – |
| Q2 2023 | $86,558 | +7.2% | 76,600 | +20.4% | 0.00% | – |
| Q1 2023 | $80,772 | +313.9% | 63,600 | +146.5% | 0.00% | – |
| Q4 2022 | $19,513 | +8.4% | 25,800 | -8.5% | 0.00% | – |
| Q3 2022 | $18,000 | -5.3% | 28,200 | -27.1% | 0.00% | – |
| Q2 2022 | $19,000 | -85.3% | 38,694 | -74.9% | 0.00% | – |
| Q1 2022 | $129,000 | -81.4% | 154,394 | -71.7% | 0.00% | -100.0% |
| Q4 2021 | $694,000 | -33.9% | 546,294 | +16.6% | 0.00% | -33.3% |
| Q3 2021 | $1,050,000 | +1180.5% | 468,594 | +1054.3% | 0.00% | – |
| Q2 2021 | $82,000 | -65.3% | 40,594 | -54.3% | 0.00% | -100.0% |
| Q1 2021 | $236,000 | +242.0% | 88,794 | +156.2% | 0.00% | – |
| Q4 2020 | $69,000 | -52.7% | 34,654 | -32.6% | 0.00% | – |
| Q3 2020 | $146,000 | -54.8% | 51,394 | -41.4% | 0.00% | -100.0% |
| Q2 2020 | $323,000 | +254.9% | 87,654 | +137.8% | 0.00% | – |
| Q1 2020 | $91,000 | +68.5% | 36,854 | +163.2% | 0.00% | – |
| Q4 2019 | $54,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,677,194 | $819,000 | 1.02% |
| BVF INC/IL | 6,861,127 | $3,352,000 | 0.16% |
| 5AM Venture Management, LLC | 1,134,511 | $554,000 | 0.14% |
| Knott David M Jr | 635,254 | $310,000 | 0.13% |
| Nantahala Capital Management | 4,819,090 | $2,355,000 | 0.12% |
| West Family Investments, Inc. | 368,910 | $180,000 | 0.07% |
| Stonepine Capital Management, LLC | 208,443 | $102,000 | 0.05% |
| JEPPSON WEALTH MANAGEMENT, LLC | 181,075 | $88,000 | 0.04% |
| Ground Swell Capital, LLC | 11,397 | $6,000 | 0.01% |
| Point72 Asset Management, L.P. | 4,200,000 | $2,052,000 | 0.01% |